The true meaning of DICE: don't ignore chance effects.
作者信息
Clarke Mike
机构信息
Centre for Public Health, Institute of Clinical Sciences, Queens University Belfast, Royal Victoria Hospital, Belfast BT12 6BJ, UK.
出版信息
J R Soc Med. 2021 Dec;114(12):575-577. doi: 10.1177/01410768211064102.
Abstract
摘要
相似文献
1
The true meaning of DICE: don't ignore chance effects.DICE的真正含义：不要忽视机遇效应。
J R Soc Med. 2021 Dec;114(12):575-577. doi: 10.1177/01410768211064102.
2
Use of re-randomized data in meta-analysis.在荟萃分析中使用重新随机化的数据。
BMC Med Res Methodol. 2005 May 10;5:17. doi: 10.1186/1471-2288-5-17.
3
Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials.评价基于药物基因组学的临床效应的验证性试验中的统计学考虑。
Clin Trials. 2010 Oct;7(5):525-36. doi: 10.1177/1740774510375455. Epub 2010 Jul 1.
4
Eligibility criteria of randomized controlled trials.随机对照试验的纳入标准。
JAMA. 2007 Jul 4;298(1):39; author reply 39-40. doi: 10.1001/jama.298.1.39-a.
5
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.随机对照试验荟萃分析中检查和解释漏斗图不对称性的建议。
BMJ. 2011 Jul 22;343:d4002. doi: 10.1136/bmj.d4002.
6
[Publication bias in trials other than RCTs].[随机对照试验以外的其他试验中的发表偏倚]
Z Evid Fortbild Qual Gesundhwes. 2011;105(3):194-200. doi: 10.1016/j.zefq.2011.03.003. Epub 2011 Apr 2.
7
Sources of bias in clinical trials.临床试验中的偏倚来源。
Am J Orthod Dentofacial Orthop. 2011 Oct;140(4):595-6. doi: 10.1016/j.ajodo.2011.06.013.
8
Methodologic issues in systematic reviews and meta-analyses.系统评价和Meta分析中的方法学问题。
Clin Orthop Relat Res. 2004 May(422):272; author reply 273-4. doi: 10.1097/01.blo.0000127919.67511.ce.
9
[Meta-analysis].
G Ital Nefrol. 2011 Sep-Oct;28(5):531-6.
10
[Lying with statistic--today: the meta-analysis].[与统计数据说谎——今日话题：荟萃分析]
Dtsch Med Wochenschr. 2010 Mar;135(9):419; author reply 419-20. doi: 10.1055/s-0030-1249179. Epub 2010 Feb 23.
引用本文的文献
1
Citation of updated and co-published Cochrane Methodology Reviews.引用更新的和共同发表的 Cochrane 方法学评论。
Syst Rev. 2023 Jul 14;12(1):120. doi: 10.1186/s13643-023-02270-w.
本文引用的文献
1
The RECOVERY trial platform: a milestone in the development and execution of treatment evaluation during an epidemic.RECOVERY试验平台：疫情期间治疗评估发展与实施过程中的一个里程碑。
J R Soc Med. 2021 Sep;114(9):443-446. doi: 10.1177/01410768211041245.
2
The mass production of systematic reviews about COVID-19: An analysis of PROSPERO records.大规模生产关于 COVID-19 的系统评价：PROSPERO 记录分析。
J Evid Based Med. 2021 Feb;14(1):56-64. doi: 10.1111/jebm.12426. Epub 2021 Feb 17.
3
The origins of the treatment of uncertainty in clinical medicine. Part 1: ancient roots, familiar disputes.临床医学中不确定性处理的起源。第1部分：古老根源，常见争议。
J R Soc Med. 2020 May;113(5):193-196. doi: 10.1177/0141076820921050.
4
Dicing with chance, life and death in systematic reviews and meta-analyses: D.I.C.E. 3, a simulation study.与机会、生死博弈：系统评价和荟萃分析中的 D.I.C.E. 3，一项模拟研究。
J R Soc Med. 2014 Mar;107(3):116-9. doi: 10.1177/0141076813514574. Epub 2014 Feb 13.
5
DICE 2: a further investigation of the effects of chance in life, death and subgroup analyses.
Int J Clin Pract. 2001 May;55(4):240-2.
6
The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?急性中风的DICE疗法奇迹：亚组分析的事实还是虚构产物？
BMJ. 1994;309(6970):1677-81. doi: 10.1136/bmj.309.6970.1677.
7
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.17187例疑似急性心肌梗死患者静脉注射链激酶、口服阿司匹林、两者并用或两者均不用的随机试验：ISIS-2。ISIS-2（第二次心肌梗死存活国际研究）协作组
Lancet. 1988 Aug 13;2(8607):349-60.
Zotero 插件